We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$253M
AUM Growth
-$1.03M
Cap. Flow
-$12.7M
Cap. Flow %
-5%
Top 10 Hldgs %
39.44%
Holding
60
New
1
Increased
16
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$4.61M
2
ADI icon
Analog Devices
ADI
+$261K
3
NVS icon
Novartis
NVS
+$200K
4
NKE icon
Nike
NKE
+$184K
5
JNJ icon
Johnson & Johnson
JNJ
+$171K

Top Sells

Rank Stock Value
1
JCI icon
Johnson Controls International
JCI
+$4.72M
2
PFE icon
Pfizer
PFE
+$3.95M
3
PG icon
Procter & Gamble
PG
+$2.7M
4
KR icon
Kroger
KR
+$2.64M
5
XOM icon
ExxonMobil
XOM
+$2.09M

Sector Composition

Rank Sector Weight
1 Healthcare 26.43%
2 Industrials 20.92%
3 Technology 17.8%
4 Consumer Staples 9.41%
5 Communication Services 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NKE icon
26
Nike
NKE
$58.7B
$4.16M 1.64%
66,435
+3,200
+5% +$184K
BSX icon
27
Boston Scientific
BSX
$67.9B
$4.12M 1.63%
166,015
– –
XLNX
28
DELISTED
Xilinx Inc
XLNX
$4.04M 1.6%
60,000
– –
ADI icon
29
Analog Devices
ADI
$175B
$3.91M 1.54%
43,900
+2,950
+7% +$261K
CL icon
30
Colgate-Palmolive
CL
$72.3B
$3.86M 1.53%
51,200
– –
RTN
31
DELISTED
Raytheon Company
RTN
$3.76M 1.48%
20,000
– –
CVS icon
32
CVS Health
CVS
$119B
$3.46M 1.37%
47,705
-21,300
-31% -$1.55M
ILMN icon
33
Illumina
ILMN
$32.6B
$3.31M 1.31%
15,574
– –
WMT icon
34
Walmart Inc
WMT
$820B
$3.26M 1.29%
99,000
– –
LOW icon
35
Lowe's Companies
LOW
$117B
$3.22M 1.27%
34,600
– –
CMCSA icon
36
Comcast
CMCSA
$96B
$3.12M 1.23%
78,000
– –
T icon
37
AT&T
T
$178B
$3.12M 1.23%
106,199
– –
CSX icon
38
CSX Corp
CSX
$95B
$2.97M 1.17%
162,000
– –
WBA
39
DELISTED
Walgreens Boots Alliance
WBA
$2.97M 1.17%
40,900
– –
SYK icon
40
Stryker
SYK
$127B
$2.83M 1.12%
18,245
+175
+1% +$26.7K
PRGO icon
41
Perrigo
PRGO
$2.01B
$2.64M 1.04%
30,315
– –
PEP icon
42
PepsiCo
PEP
$193B
$2.52M 0.99%
21,000
– –
GOOG icon
43
Alphabet (Google) Class C
GOOG
$4.19T
$2.36M 0.93%
45,120
– –
DD icon
44
DuPont de Nemours
DD
$18.5B
$1.83M 0.72%
10,125
– –
ESRX
45
DELISTED
Express Scripts Holding Company
ESRX
$1.79M 0.71%
24,000
– –
ZTS icon
46
Zoetis
ZTS
$32B
$1.79M 0.71%
24,818
– –
ADBE icon
47
Adobe
ADBE
$116B
$1.58M 0.62%
9,000
– –
IFF icon
48
International Flavors & Fragrances
IFF
$22.4B
$1.53M 0.6%
10,000
– –
BMY icon
49
Bristol-Myers Squibb
BMY
$136B
$1.42M 0.56%
23,200
+1,350
+6% +$84.4K
ADNT icon
50
Adient
ADNT
$1.47B
$894K 0.35%
11,357
– –
1
2
3

Similar funds

PLU
Performa Ltd (US) Charleston, South Carolina $620M AUM 19.43% 1-Year Est. Return
RR
Robotti Robert $620M AUM 55.18% 1-Year Est. Return
TAIM
Te Ahumairangi Investment Management Wellington, New Zealand $620M AUM 14.43% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
GPWA
Great Point Wealth Advisors Boston, Massachusetts $619M AUM 14.72% 1-Year Est. Return
MAC
Mason & Associates (California) Los Angeles, California $619M AUM 29.44% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $621M AUM 15.59% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $621M AUM 34.06% 1-Year Est. Return

Chad R. Baker's Q4 2017 Portfolio in Review

As of Q4 2017, Chad R. Baker held 60 positions worth $253M, down 0.41% from $254M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Chad R. Baker withdrew a net $12.7M in Q4 2017, closing 3 positions and reducing 4 holdings. Its most notable exit was Johnson Controls International, an estimated $4.72M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Industrials and Technology.

Against the trend, Chad R. Baker opened a new position in Broadcom worth $4.56M.

  • Chad R. Baker's largest Q4 2017 buy was Broadcom: 177,400 shares worth $4.56M.
  • Chad R. Baker added most to Analog Devices in Q4 2017, an estimated $261K increase.
  • Chad R. Baker's biggest Q4 2017 reduction was Pfizer, cutting an estimated $3.95M.
  • Chad R. Baker fully exited Johnson Controls International in Q4 2017, selling an estimated $4.72M.
  • Chad R. Baker's ten largest holdings make up 39% of its $253M portfolio in Q4 2017.
  • Chad R. Baker opened 1 new position and closed 3 in Q4 2017.
  • Chad R. Baker's portfolio value fell 0.41% quarter-over-quarter to $253M.

Based on Chad R. Baker's 13F filing for Q4 2017, filed 13 Feb 2018.